Post by Verve Ventures

Neo Medical has completed its first surgical case at the Hospital for Special Surgery (HSS) in New York. This is one of the world's foremost orthopedic and spine institutions. Traditional spinal fusion surgery relies on systems comprising several hundred components. This complexity drives extended OR preparation time, infection risk from reusable instrument sterilization, and significant coordination demands on the entire surgical team. Neo Medical addresses these inefficiencies at the system level. Their Swiss-made platform reduces the surgical toolkit to five instruments and fourteen implants, all sterile and single-use. This eliminates on-site sterilization, compresses OR setup time, and standardizes the operative workflow for every member of the team. Why this matters: - Neo's single-use sterile architecture reduces the environmental footprint of spinal fusion surgery by 75% compared to legacy reusable systems - The first case at HSS validates Neo's platform in one of the most demanding clinical environments globally - Surgeon feedback centered on workflow integration across the entire OR team: a signal that Neo has solved an operational problem, not only a technical one As early investors in Neo Medical since 2020, we are proud to support this milestone as the company's U.S. presence expands into tier-1 institutions. It is a meaningful validation of our Frontiers in Health & Biotech investment thesis. #DeepTech #MedTech #SpineSurgery #HealthTech #SurgicalInnovation #FrontiersInHealth #PortfolioNews